0

Guanfacine Hydrochloride Extended-Release for Attention Deficit Hyperactivity Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet]

Sharada Harricharan, Lorna Adcock

PMID: 30329242

Abstract:

Since this time, Guanfacine hydrochloride extended-release's (GXR) role in attention-deficit/hyperactivity disorder (ADHD) therapy has continued to be studied. The aim of this review is to assist decision-makers and prescribers by evaluating the recently published evidence on the clinical effectiveness and cost-effectiveness of GXR for the treatment children and adolescents with ADHD. Clinical guidelines will also be examined.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP29110483-A Guanfacine hydrochloride Guanfacine hydrochloride 29110-48-3 Price
qrcode